Cargando…
Human Gut Microbiota and Drug Metabolism
The efficacy of drugs widely varies in individuals, and the gut microbiota plays an important role in this variability. The commensal microbiota living in the human gut encodes several enzymes that chemically modify systemic and orally administered drugs, and such modifications can lead to activatio...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308113/ https://www.ncbi.nlm.nih.gov/pubmed/35869999 http://dx.doi.org/10.1007/s00248-022-02081-x |
_version_ | 1784752917026177024 |
---|---|
author | Pant, Archana Maiti, Tushar K. Mahajan, Dinesh Das, Bhabatosh |
author_facet | Pant, Archana Maiti, Tushar K. Mahajan, Dinesh Das, Bhabatosh |
author_sort | Pant, Archana |
collection | PubMed |
description | The efficacy of drugs widely varies in individuals, and the gut microbiota plays an important role in this variability. The commensal microbiota living in the human gut encodes several enzymes that chemically modify systemic and orally administered drugs, and such modifications can lead to activation, inactivation, toxification, altered stability, poor bioavailability, and rapid excretion. Our knowledge of the role of the human gut microbiome in therapeutic outcomes continues to evolve. Recent studies suggest the existence of complex interactions between microbial functions and therapeutic drugs across the human body. Therapeutic drugs or xenobiotics can influence the composition of the gut microbiome and the microbial encoded functions. Both these deviations can alter the chemical transformations of the drugs and hence treatment outcomes. In this review, we provide an overview of (i) the genetic ecology of microbially encoded functions linked with xenobiotic degradation; (ii) the effect of drugs on the composition and function of the gut microbiome; and (iii) the importance of the gut microbiota in drug metabolism. |
format | Online Article Text |
id | pubmed-9308113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-93081132022-07-25 Human Gut Microbiota and Drug Metabolism Pant, Archana Maiti, Tushar K. Mahajan, Dinesh Das, Bhabatosh Microb Ecol Human Microbiome The efficacy of drugs widely varies in individuals, and the gut microbiota plays an important role in this variability. The commensal microbiota living in the human gut encodes several enzymes that chemically modify systemic and orally administered drugs, and such modifications can lead to activation, inactivation, toxification, altered stability, poor bioavailability, and rapid excretion. Our knowledge of the role of the human gut microbiome in therapeutic outcomes continues to evolve. Recent studies suggest the existence of complex interactions between microbial functions and therapeutic drugs across the human body. Therapeutic drugs or xenobiotics can influence the composition of the gut microbiome and the microbial encoded functions. Both these deviations can alter the chemical transformations of the drugs and hence treatment outcomes. In this review, we provide an overview of (i) the genetic ecology of microbially encoded functions linked with xenobiotic degradation; (ii) the effect of drugs on the composition and function of the gut microbiome; and (iii) the importance of the gut microbiota in drug metabolism. Springer US 2022-07-23 /pmc/articles/PMC9308113/ /pubmed/35869999 http://dx.doi.org/10.1007/s00248-022-02081-x Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Human Microbiome Pant, Archana Maiti, Tushar K. Mahajan, Dinesh Das, Bhabatosh Human Gut Microbiota and Drug Metabolism |
title | Human Gut Microbiota and Drug Metabolism |
title_full | Human Gut Microbiota and Drug Metabolism |
title_fullStr | Human Gut Microbiota and Drug Metabolism |
title_full_unstemmed | Human Gut Microbiota and Drug Metabolism |
title_short | Human Gut Microbiota and Drug Metabolism |
title_sort | human gut microbiota and drug metabolism |
topic | Human Microbiome |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308113/ https://www.ncbi.nlm.nih.gov/pubmed/35869999 http://dx.doi.org/10.1007/s00248-022-02081-x |
work_keys_str_mv | AT pantarchana humangutmicrobiotaanddrugmetabolism AT maititushark humangutmicrobiotaanddrugmetabolism AT mahajandinesh humangutmicrobiotaanddrugmetabolism AT dasbhabatosh humangutmicrobiotaanddrugmetabolism |